Loading…
Responsibility in Drug and Device Advertising Act of 2008
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2009 · second_quarter · Health Issues
Affordable Health Choice Act. S301 Physician Payments Sunshine Act 2009. HR380, S623, Access to Life-Saving Medicine Act; Follow-on biologics, importation, HR3610 Food and Drug Safety Act of 2007: Import safety; HR5839, Safeguard Americans Pharmaceuticals Act; S2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR1427 and HR1038, Access to Life-Saving Medicine Act; follow-on biologics; HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR3610, Food and Drug Import Safety Act of 2007; Import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Health Issues
HR 2 Children's Health Insurance Program Reauthorization Act 2009. S301 Physician Payments Sunshine Act 2009. HR380, S623, Access to Life-Saving Medicine Act; Follow-on biologics, importation, HR3610 Food and Drug Safety Act of 2007: Import safety; HR5839, Safeguard Americans Pharmaceuticals Act; S2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR1427 and HR1038, Access to Life-Saving Medicine Act; follow-on biologics; HR1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR3610, Food and Drug Import Safety Act of 2007; Import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Communications/Broadcasting/Radio/TV
S 234, Wireless Innovation Act HR 1597, Wireless Innovation Act S 337, White Spaces Act of 2007 S 602 Child Safe Viewing Act HR 2102, Free Flow Information Act of 2007 S 215, Internet Freedom Preservation Act HR 2738, Family and Consumer Choice Act HR 2821, Television Freedom Act of 2007 HR 2566, National Digital Television Consumer Education Act HR 2905, Broadcast Freedom Act of 2007 HR 608 Digital Television Consumer Education Act of 2007 HR 1320, Interference Protection for Existing Television Band Devices S 1780, Protecting Children from Indecent Programming Act HR 2900, Food and Drug Administration Act Amendments of 2007 S 1082, Food and Drug Administration Act Amendments of 2007 HR 2331 First Responders Act S 1223, First Responders Act China Market Access S2035 Free Flow Information Act HR 2566 Media Ownership Act S 2332 Media Ownership Act HR 3559 Protecting Children from Indecent Programming S1267, Free Flow Information Act of 2007 S2831, FTC Reauthorization Act S1170, "Connect the Nation Act" HR 3627, "Connect the Nation Act" HR 3862, Preparing America's Seniors for Digital Transition HR 5435, DTV Border Fix S 2507, DTV Border Fix Retransmission consent Product Placement a la carte HR 2905, Fairness Doctrine Fiscal Year 2009 Appropriations Mark HR 6209, Commercial Ads Loudness Mitigation Act S 3154, Commercial Ads Loudness Mitigation Act S 3156, Commercial Ads Loudness Mitigation Act DOJ to adopt new rules governing access under ADA for close captioning/video description in movies HR 6320, On Line Captioning HR 2320, National Amusement Park Ride Safety Act Broadband deployment provisions of Stimulus II HR 6151 Responsibility in Drug and Device Advertising Act of 2008 HR 4083 Non Prescription Drug Modernization Act S 3446 Bill to Create Minority Tax Credits HR 7013 Short Term Analog Flash and Emergency Readiness Act S 3663 Short Term Analog Flash and Emergency Readiness Act
2008 · fourth_quarter · Communications/Broadcasting/Radio/TV
S 234, Wireless Innovation Act HR 1597, Wireless Innovation Act S 337, White Spaces Act of 2007 S 602 Child Safe Viewing Act HR 2102, Free Flow Information Act of 2007 S 215, Internet Freedom Preservation Act HR 2738, Family and Consumer Choice Act HR 2821, Television Freedom Act of 2007 HR 2566, National Digital Television Consumer Education Act HR 2905, Broadcast Freedom Act of 2007 HR 608 Digital Television Consumer Education Act of 2007 HR 1320, Interference Protection for Existing Television Band Devices S 1780, Protecting Children from Indecent Programming Act HR 2900, Food and Drug Administration Act Amendments of 2007 S 1082, Food and Drug Administration Act Amendments of 2007 HR 2331 First Responders Act S 1223, First Responders Act China Market Access S2035 Free Flow Information Act HR 2566 Media Ownership Act S 2332 Media Ownership Act HR 3559 Protecting Children from Indecent Programming S1267, Free Flow Information Act of 2007 S2831, FTC Reauthorization Act S1170, "Connect the Nation Act" HR 3627, "Connect the Nation Act" HR 3862, Preparing America's Seniors for Digital Transition HR 5435, DTV Border Fix S 2507, DTV Border Fix Retransmission consent Product Placement a la carte HR 2905, Fairness Doctrine Fiscal Year 2009 Appropriations Mark HR 6209, Commercial Ads Loudness Mitigation Act S 3154, Commercial Ads Loudness Mitigation Act S 3156, Commercial Ads Loudness Mitigation Act DOJ to adopt new rules governing access under ADA for close captioning/video description in movies HR 6320, On Line Captioning HR 2320, National Amusement Park Ride Safety Act Broadband deployment provisions of Stimulus II HR 6151 Responsibility in Drug and Device Advertising Act of 2008 HR 4083 Non Prescription Drug Modernization Act S 3446 Bill to Create Minority Tax Credits HR 7013 Short Term Analog Flash and Emergency Readiness Act S 3663 Short Term Analog Flash and Emergency Readiness Act
| Democratic |
| IL |
| Donna M. Christensen | Democratic | VI |
| Jo Ann Emerson | Republican | MO |
| Lloyd Doggett | Democratic | TX |
| Peter A. DeFazio | Democratic | OR |
Client expense: $4,260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Aeronautics & Space Administration (NASA), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
Client expense: $4,260,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Aeronautics & Space Administration (NASA), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2008 · fourth_quarter · Health Issues
HR 380, S 623, Access to Life-Saving Medicine Act; Follow-on biologics, importation; HR 3610 Food and Drug Import Safety Act of 2007; Import safety; HR 5839, Safeguard Americans Pharmaceuticals Act; S 2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption. HR 1038, Access to Life-Saving Medicine Act; follow-on biologics; H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007; follow-on biologics; HR 3610, Food and Drug Import Safety Act of 2007: import safety HR 6151, Responsibilty in Drug and Device Advertising Act of 2008: Direct-to-consumer advertising; S 242, Pharmaceutical Market Acess and Drug Safety Act of 2007: importation; S 334, Healthy Americans Act: non-interference; S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs; S 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics; S 2663, CPSC Reform Act: importation; S 3398, Medical Device Safety Act of 2008: preemption issues; S 3409, Drug and Device Accountability Act of 2008: import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151, Direct to Consumer Advertising of Drugs
Client expense: $65,235 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $260,000 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: Direct-to-consumer drug advertising H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Client expense: $6,170,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Health Issues
H.R. 6381, Medical Device Safety Act H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008 H.R. 2193, Animal Protection Accountability Improvement Act Research on Bariatric Surgery
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · fourth_quarter · Advertising
H.R. 1108, Family Smoking Prevention and Tobacco Control Act (Adverting Provisions); S. 625, Family Smoking Prevention and Tobacco Control Act (Advertising Provisions); S. 2831 Federal Trade Commission Reauthorization Act of 2008 (Reauthorization of a Federal Agency); DirectTo-Consumer (DTC) Pharmaceutical Advertising (General); Online Advertising (General); H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008 (Advertising Provisions)
Client expense: $173,169 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
HR 2193 Animal Protection Accountability Improvement Act; HR 6381 Medical Device Safety Act; HR 6151 Responsibility in Drug and Device Advertising Act of 2008; General issues related to healthcare and healthcare reimbursement.
Client expense: $480,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Health Issues
FDA Sentinel Initiative (post market surveillance); H.R. 3580; FDA Guidance Documents; H.R. 3160 - Import Safety; Federal Preemption (S.3398 and H.R. 6381); Direct to Consumer Ads (H.R. 6151)
Client expense: $16,115 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · fourth_quarter · Advertising
HR6151 Responsibility in Drug and Device Advertisng Act of 2008. DTC drug advertising issues.
Client expense: $115,517 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; HR 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · fourth_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisements
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
HR 2193 Animal Protection Accountability Improvement Act; HR 6381 Medical Device Safety Act; HR 6151 Responsibility in Drug and Device Advertising Act of 2008; General issues related to the healthcare industry; General issues regarding domestic and international reimbursement and procurement for medical products.
Client expense: $450,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2008 · third_quarter · Health Issues
H.R. 380, Pharmaceutical Market Access and Drug Safety Act of 2007: importation H.R. 1014, Heart Disease Education, Analysis Research, and Treatment for Women Act: reporting and analysis of patient data H.R. 1038, Access to Life-Saving Medicine Act: follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007: follow-on biologics H.R. 3610, Food and Drug Import Safety Act of 2007: import safety H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health H.R. 5629, Pathway for Biosimilars Act: follow-on biologics H.R. 5683, The Government Accountability Office Act: disclosure of data H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008: anti-counterfeiting H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008: direct-to-consumer drug advertising H.R. 6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008: on-line pharmacy issues H.R. 6378, Strengthening of FDA Integrity Act of 2008: debarment H.R. 6381, Medical Device Safety Act of 2008: preemption issues H.R. 6388 The Government Accountability Office Improvement Act of 2008: disclosure of data H.R. 6432, Animal Drug User Fee Amendments of 2008: technical corrections to FDAAA H.R. 6820, Water Assessment and Treatment Evaluation Research Study Act of 2008: pharmaceuticals in drinking water and human health S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007: importation S. 334, Healthy Americans Act: non-interference S. 623, Access to Life-Saving Medicine Act: follow-on biologics S. 1693, Wired for Health Care Quality Act: health information technology and health care quality and costs S. 1695, Biologics Price Competition and Innovation Act of 2007: follow-on biologics S. 2663, CPSC Reform Act: importation S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008: public health S. 3046, Access, Compassion, Care, and Ethics for Seriously Ill Patients Act (ACCESS Act): access to investigational drugs and related issues S. 3398, Medical Device Safety Act of 2008: preemption issues S. 3409, Drug and Device Accountability Act of 2008: import safety S. 3560, QI Program Supplemental Funding Act of 2008: antibiotic exclusivity provisions S. 3633, Transparency in Drug Labeling Act: country of origin labeling for drugs
Client expense: $5,420,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Economic Council (NEC), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
2008 · third_quarter · Health Issues
H.R. 6381, Medical Device Safety Act H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008 H.R. 2193, Animal Protection Accountability Improvement Act Research on Bariatric Surgery
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
H.R. 1108, Family Smoking Prevention and Tobacco Control Act (Adverting Provisions); S. 625, Family Smoking Prevention and Tobacco Control Act (Advertising Provisions); S. 2831 Federal Trade Commission Reauthorization Act of 2008 (Reauthorization of a Federal Agency); DirectTo-Consumer (DTC) Pharmaceutical Advertising (General); Online Advertising (General); H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008 (Advertising Provisions)
Client expense: $160,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Health Issues
Pediatric Cough and Cold Medicines Regulation and Advertising of OTC's, HR 4083 and S. 2311 HR 6151 Direct to Consumer Advertising of Drugs
Client expense: $116,217 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · third_quarter · Advertising
HR6151 Responsibility in Drug and Device Advertising Act of 2008. DTC drug advertising issues.
Client expense: $135,853 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Health Issues
Pediatric Cough and Cold Medicines; Regulation and Advertising of OTC's, H.R. 4083 and S. 2311 H.R. 6151 Direct to Consumer Advertising of Drugs
Client expense: $150,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
HR 6151 Responsibility in Drug and Device Advertising Act of 2008.DTC drug advertising issues.
Client expense: $140,181 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Pharmacy
S. 2311 and H.R. 4083, Non-Prescription Drug Modernization Act of 2007, provisions to grant the FDA authority over advertising for over-the-counter drugs H.R. 6151, Responsibility in Drug and Device Advertising Act of 2008, provisions imposing a three-year moratorium on prescription drug advertising and requiring fair balance in drug advertisemetns
Client expense: $240,000 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · second_quarter · Advertising
H.R. 6151 Responsibility in Drug and Device Advertising Act of 2008; H.R.5605 Physician Payments Sunshine Act of 2008; S. 334 Healthy Americans Act; S. 484 Enhancing Drug Safety and Innovation Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007; H.R. 2117 Health Freedom Protection Act ; S. 2311 Nonprescription Drug Modernization Act; H.R. 4083 Nonprescription Drug Modernization Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE